Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10
Published July 26, 2023 · Recall initiated: June 21, 2023
Summary
FDA records drug Class II recall D-0923-2023, published July 26, 2023 and initiated June 21, 2023. Recalling firm: Dr Reddy's Laboratories Limited; Status: Ongoing; Reported quantity: 17,548 1000-countbottles; Lot: Lot: T2100585, T2100586, T2100587, Exp 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Get an email if TIZANIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr Reddy's Laboratories Limited
- Distributor
- Nationwide in the USA
- UPC
- 0355111180104
- Lot
- Lot: T2100585, T2100586, T2100587, Exp 12/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDATizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, SrikakulamJanuary 17, 2024
- FDALoteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mLJuly 26, 2023
- FDAMEDLINE NON-STERILE PVP SOLUTION, packaged in kits as follows: OISC HAND BEAR, Model Number DYNJ902348LJuly 19, 2023
- FDATizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only,July 12, 2023
- FDATizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottlesJuly 12, 2023
- FDATizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited,August 25, 2021
Questions about this recall
Was Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10 recalled?
Yes. FDA published recall D-0923-2023 on July 26, 2023. Reported hazard: Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
What should I do if I have this product?
Stop using or selling the product and check the official FDA notice (D-0923-2023) for return or repair instructions.
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.